Examples of FFDC Act in a sentence
Scientists in ORA’s 13 laboratories typically have analyzed more than 41,000 product samples each year to determine their adherence to the FDA’s standards.Section 516 of the FFDC Act gives FDA the authority to ban devices that present substantial deception or unreasonable and substantial risk of illness or injury.
Within 60 days, FDA will render a decision classifying the device according to criteria in 513(a)(1) of FFDC Act.
Elder, Tradingem k bohatství, Tetčice, Impossible, s.r.o., 2006, p.300.[4] M.
Section 519(a) of the FFDC Act as amended by the SMDA of 1990 required FDA to establish a system for monitoring and tracking serious adverse events that resulted from the use or misuse of medical devices.
Section 201(k) of the FFDC Act defines a “label” as a: “display of written, printed, or graphic matter upon the immediate container of any article.” Section 201(m) defines “labeling” as: “all labels and other written, printed, or graphic matter upon any article or any of its containers or wrappers, or accompanying such article” at any time while a device is held for sale after shipment or delivery for shipment in interstate commerce.
FDA aims to review most special 510(k)s in 30 days.Under the FFDC Act, first-of-a-kind devices lacking a legally marketed predicate would automatically be designated Class III.
New devices which are not classified as Class I or II by another means, are automatically designated as Class III unless the manufacturer files a request or petition for reclassification under Section 513(f)(2) of the FFDC Act (See also 21 CFR§ 860.3(c)(3)).
On occasion, District compliance units may initiate case development activities and may issue investigative assignments whenever review of the inspection report raises the possibility of severe violations of the FFD&C Act or other Federal statutes.
The term ‘labeling’ is defined in the FFDC Act as including all printed matter accompanying any article.
Preclinical data is almost never required for Class I and II devices, or IVDs. For both drugs and devices, valid scientific evidence is required to meet a threshold for “safety” and “effectiveness.”46 FDAMA modified FFDC Act requirements from two to one adequate and well-controlled study, and also permitted use of surrogate endpoints for approval rather than clinical endpoints.